Atlas Trials

Safety and Pharmacokinetics of Subcutaneous Dose of IMG-007 in Healthy Participants

Clinical trial NCT06304740 · TERMINATED

Trial details

NCT number
NCT06304740
Sponsor
Inmagene LLC
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Volunteers
Start date
2024-03-06
Primary completion
2024-08-28
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.